- €497.92m
- €486.12m
- €115.70m
- 65
- 51
- 56
- 60
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 84 | 120 | 101 | 116 |
Cost of Revenue | ||||
Gross Profit | 80.9 | 117 | 97.4 | 113 |
Selling / General / Administrative Expenses | ||||
Depreciation and Amortization | ||||
Unusual Expense / Income | ||||
Other Operating Expenses | ||||
Total Operating Expenses | 51.7 | 62.9 | 69.8 | 75.5 |
Operating Profit | 32.3 | 56.6 | 30.9 | 40.2 |
Net Income Before Taxes | 32.3 | 56.6 | 30.9 | 40.2 |
Provision for Income Taxes | ||||
Net Income After Taxes | 25.5 | 45.4 | 25.1 | 32 |
Minority Interest | ||||
Net Income Before Extraordinary Items | ||||
Net Income | 23.6 | 38.7 | 20.8 | 28.7 |
Adjustments to Net Income | ||||
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | 23.5 | 38.8 | 20.7 | 28.8 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | 0.985 | 1.63 | 0.848 | 1.12 |
Dividends per Share | ||||
Special Dividends per Share |